文献速递肾移植慢性肾脏病

远程医疗用于肾移植与慢性肾脏病患者门诊照护

Telemedicine for Outpatient Care of Kidney Transplant and CKD Patients.
PubMed 文献 · Kidney Int Rep · 2021-02-26

这项单中心前瞻性病例对照研究纳入64例肾移植受者或慢性肾脏病患者,评估视频会议远程医疗的可行性、可持续性与临床结局。远程医疗组第一年视频会议使用率为71%,第二年降至50%,肌酐与血压无显著组间差异,出行距离分别减少48%和37%。

要点

  • 视频会议远程医疗在肾移植和慢性肾脏病门诊中可行且可持续。
  • 远程医疗组肌酐和血压与标准照护组无显著差异。
  • 远程医疗可大幅减少患者出行距离,患者满意度保持较高。

核心结论

  • 视频会议远程医疗在肾移植受者和慢性肾脏病患者中可行且可持续,临床结局与标准照护相当。

研究设计与样本

  • 单中心、前瞻性、2年纵向病例对照研究,共招募64例参与者,远程医疗组与对照组各32例。
  • 远程医疗组纳入标准包括到医院距离≥15 km,对照组按移植或CKD状态、年龄和性别匹配。

主要发现

  • 远程医疗组第一年视频会议使用率为71%(IQR 50.0-100.0),第二年显著降至50.0%(IQR 33.3-71.4),P<0.01。
  • 两组间肌酐和血压无显著差异,包括在肾移植受者和CKD亚组分析中。
  • 两组患者满意度均保持较高。
  • 与无视频会议时所需出行距离相比,远程医疗组出行距离第一年减少48%(16,644 km),第二年减少37.0%(8177 km)。

关键数值与推荐

  • 可行性主要结局定义为远程医疗组每位患者第一年≥50%的咨询通过视频会议进行。
  • 共64例参与者,远程医疗组和对照组各32例,无基线差异;男性占65.6%,平均年龄63.9岁(SD=12.3岁)。

临床怎么用

  • 视频会议远程医疗可作为肾移植受者和慢性肾脏病患者门诊照护的可行选择,有助于减少出行距离。
  • 需关注远程医疗使用率随时间下降的趋势,并采取措施维持可持续性。

局限性

  • 研究为单中心、样本量较小,需更大规模研究尤其是针对肾移植受者来证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Telehealth videoconferencing (TVC) may improve access in rural areas, but reported uptake and outcomes among kidney transplant recipients (KTRs) and chronic kidney disease (CKD) patients are limited. This study aimed to assess the feasibility, sustainability, and clinical outcomes of TVC for this patient population. METHODS: A total of 64 participants were recruited in this single-center, prospective, 2-year longitudinal, case-control study. Inclusion criteria for the telemedicine group included travel of ≥15 km to the hospital, and the control group was matched for transplant or CKD status, age, and sex. The primary outcome was feasibility (≥50% of consultations for each individual patient in the telemedicine group being conducted by TVC in year 1). Secondary outcomes were sustainability of telemedicine, change in blood pressure and creatinine, hospitalization, and travel distance. RESULTS: There were 32 participants in both the telemedicine and control arms, with no baseline differences. The majority were male (65.6%) and the mean age was 63.9 years (SD = 12.3 years). TVC uptake in year 1 in the telemedicine arm was 71% (interquartile range [IQR] = 50.0-100.0) but reduced significantly in year 2 (50.0% [IQR = 33.3-71.4], P < 0.01). No significant differences in creatinine or blood pressure were observed between groups, including in the KTRs and CKD subgroup analysis. Patient satisfaction remained high for both groups. Compared with travel distance required if TVC was unavailable, travel distance in the TVC group decreased by 48% (16,644 km) in year 1 and by 37.0% (8177 km) in year 2. CONCLUSION: TVC was feasible and sustainable, with outcomes comparable to those of standard care. Larger studies, especially among KTRs, are needed to confirm these findings.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Lambooy S, Krishnasamy R, Pollock A, et al. Telemedicine for Outpatient Care of Kidney Transplant and CKD Patients. Kidney Int Rep. 2021. PMID: 34013104. doi:10.1016/j.ekir.2021.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。